Multikinase inhibitors

What are Multikinase inhibitors?

Multikinase inhibitors work by inhibiting multiple intracellular and cell surface kinases, some of which are implicated in tumor growth and metastatic progression of cancer, thus decreasing tumor growth and replication. Multikinase inhibitors may be used to treat advanced kidney cancer as well as other specific types of cancer.

Types of Multikinase inhibitors

Please refer to the drug classes listed below for further information.

Medical conditions treated or associated with multikinase inhibitors:

Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Alopecia
Anaplastic Large Cell Lymphoma - ALK-Positive
Biliary Tract Tumor
Bladder Cancer
Breast Cancer
Cholangiocarcinoma
Chronic Fibrosing Interstitial Lung Disease With A Progressive Phenotype
Chronic Myelogenous Leukemia
Colorectal Cancer
Endometrial Cancer
Erdheim-Chester Disease
Follicular Lymphoma
Gastrointestinal Stromal Tumor
Graft-versus-host disease
Hepatic Tumor
Hepatocellular Carcinoma
Histiocytic Neoplasm
Idiopathic Pulmonary Fibrosis
Inflammatory Myofibroblastic Tumor
Low-Grade Glioma
Marginal Zone Lymphoma
Melanoma, Metastatic
Myelofibrosis
Myeloid/Lymphoid Neoplasms
Myeloproliferative Disorders
Neurofibromatosis
Non-Small Cell Lung Cancer
Pancreatic Cancer
Plaque Psoriasis
Polycythemia Vera
Renal Cell Carcinoma
Solid Tumors
Systemic Mastocytosis
Systemic Sclerosis-Associated Interstitial Lung Disease
Tenosynovial Giant Cell Tumor
Thyroid Cancer
Urothelial Carcinoma

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer